Significant changes have been recorded in the concentration of sulfhyd
ryl groups, histidine, lipoproteins, catalase activity, saponin resist
ance, and kinetics of chemiluminescent responses of red blood cells in
lymphoma patients. Lymphosarcoma is characterized by changes in the s
tructure and function of red blood cells at the early stage of the pro
cess, whereas in lymphogranulomatosis changes are observed with the di
sease progressing, when pronounced signs of tumor intoxication are not
ed and anemia is present. In lymphosarcoma patients an increase of per
ipheral blood mononuclears is recorded which expresses the erythroid d
ifferentiating antigens with the use of monoclonal antibodies against
glycoforin A (ZAE-3) and human erythroblast antigen AG-EB (HAE-9). In
lymphogranulomatosis patients it was not detected.